Zhitong Finance App News, Wangshan Wangshui-B (02630) issued an announcement. Recently, the company received a notice from all pre-initial public sale investors, including controlling shareholders. According to this, based on high recognition of the value of the company's R&D pipeline, commercialization prospects of approved drugs, and the core management team, they each promised not to reduce their respective holdings of the company's shares during the extended ban period for 7 or 4 months thereafter (extended ban period).

The Company believes that the extension of the sales ban period indicates that the aforementioned shareholders are confident in the future prospects and long-term value of the Company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.